By investigating the association between tau and functional connectivity this study aims to deepen the understanding of mechanisms of tau progression and AD heterogeneity, potentially informing more targeted therapeutic strategies and tailored clinical trial end points. This evidence concerns the gene MAPT and Alzheimer disease.